PPIH is a novel diagnostic biomarker associated with immune infiltration in cholangiocarcinoma
The results of this study suggest that PPIH is a potential novel biomarker with significant diagnostic value for patients with CHOL. PPIH may also play a role in modulating the immune microenvironment, contributing to poor prognosis.
Authors
- Rui Xie (ORCID: https://orcid.org/0000-0003-0357-6702)
- Chuan Zhang (ORCID: https://orcid.org/0000-0002-9311-0799)
- Jun Ye (ORCID: https://orcid.org/0009-0009-9611-4005)
- Zhitao Chen (ORCID: https://orcid.org/0000-0002-7054-6549)
- Peng Ren (ORCID: https://orcid.org/0009-0001-3338-2266)
- Haini Chen
Institutions
- Guiyang Medical University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1186/s12885-025-13607-0
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.05